Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_provenance.
- NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_provenance.
- NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_assertion evidence source_evidence_literature NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_provenance.
- NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_assertion SIO_000772 21942912 NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_provenance.
- NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_assertion wasDerivedFrom befree-20150227 NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_provenance.
- NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_assertion wasGeneratedBy ECO_0000203 NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_provenance.